Dr. Barry Dworkin

Prostate cancer screening is not as clear cut as we would like it to be. In the end, a frank discussion about the risks and benefits using the available evidence will allow the patient to decide if they wish to pursue this option.

Medical Mythbusting Commentary for March 5, 2024

Source:
What you should know to reduce the risk of prostate cancer

Reference:
PROSTATE CANCER—CLINICIAN SUMMARY

Related posts:

  1. Repeating PSA test reduces number of unnecessary biopsies
  2. "New" PSA guidelines from Prostate Cancer Canada will cause more harm than good and is not supported by evidence
  3. Cancer Care Ontario advises against prostate cancer screening with PSA test
  4. Prostate Cancer screening blood test uses a combination PSA and epigenetic markers to improve accuracy and reduce false positive results. Further evaluation in larger population cohorts recommended by study authors.